Cargando…
Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
Within the last couple of years, the understanding of the molecular mechanisms that drive the pathogenesis of diffuse large B-cell lymphoma (DLBCL) has significantly improved. Large-scale gene expression profiling studies have led to the discovery of several molecularly defined subtypes that are cha...
Autor principal: | Lenz, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491687/ https://www.ncbi.nlm.nih.gov/pubmed/26010601 http://dx.doi.org/10.3390/cancers7020812 |
Ejemplares similares
-
Novel therapeutic targets in diffuse large B-cell lymphoma
por: Lenz, Georg
Publicado: (2013) -
Molecular classification and therapeutics in diffuse large B-cell lymphoma
por: Shimkus, Gaelen, et al.
Publicado: (2023) -
Molecular profiling of EBV associated diffuse large B-cell lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2023) -
Diffuse large B-cell lymphoma and new insights into its pathobiology and implication in treatment
por: Mamgain, Garima, et al.
Publicado: (2022) -
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
por: Papageorgiou, Sotirios G., et al.
Publicado: (2021)